# Clinical Study on CAR-T Targeting Igβ Targets in Refractory Relapsed Non-Hodgkin's Lymphoma

> **NCT05312476** · PHASE2 · UNKNOWN · sponsor: **The First Affiliated Hospital of Soochow University** · enrollment: 12 (estimated)

## Conditions studied

- Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma

## Interventions

- **DRUG:** Chimeric Antigen Receptor T Cells (CAR-T) Targeting Igβ Targets

## Key facts

- **NCT ID:** NCT05312476
- **Lead sponsor:** The First Affiliated Hospital of Soochow University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-02-10
- **Primary completion:** 2025-02-10
- **Final completion:** 2025-02-10
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2022-04-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05312476

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05312476, "Clinical Study on CAR-T Targeting Igβ Targets in Refractory Relapsed Non-Hodgkin's Lymphoma". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05312476. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*